Maya Chen is an HR consultant with over 10 years of experience in performance management and organizational development.
Grammy-winning R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic malignancy.
“The shining star of our family has dimmed his light for us in the present world,” his relatives confirmed. “After a prolonged and courageous battle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his followers around the globe as D’Angelo, has been called home.”
D’Angelo left an indelible mark on the music industry with his pioneering neo-soul sound and partnerships with renowned musicians.
He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The album achieved the fourth spot on the R&B charts, earned platinum status later that year, and received several award nominations.
However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The record debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the singer, famously stripped down to his midsection, singing straight into the lens.
D’Angelo stepped back from the public eye after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious car crash that left him in grave health.
More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the soul music rankings and a award for Top R&B Record.
Once more, in his own enigmatic fashion, D’Angelo made only a few public outings in the following years.
The musician was scheduled as a headliner for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”
Even though information is limited about D’Angelo’s well-being in the months leading up to his death, he had reportedly been hospitalized for months and in hospice for two weeks.
D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the illness, on a brilliant talent whose life was ended too soon.
“We are grieved that he can only provide cherished moments with his family, but we are forever thankful for the legacy of extraordinarily moving music he leaves behind,” his kin expressed.
Pancreatic cancer impacts the pancreas, a small organ that generates the hormone insulin and plays an essential role in breaking down food, among other functions. The position and dimensions of the organ in the body make it more difficult to detect cancer.
Even though pancreatic cancer accounts for only approximately three percent of malignancy cases annually in the United States, it is causes 7% of cancer deaths.
Nearly 70,000 individuals will be found to have this condition and about fifty-two thousand will succumb to the disease in 2025.
“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have limited and ineffective treatment options, and a smaller window to make a significant difference on the lives of people,” said a medical oncologist.
Since pancreatic cancer seldom produces initial signs, it’s often identified only once the condition is advanced. Although a patient has indicators they are usually nonspecific and may be mistaken for a number of common illnesses.
“As of yet, there is no good way to detect pancreatic cancer in the initial phases, apart from listening to your body and speaking with your doctor if there are unfamiliar signs,” explained a health expert.
Common symptoms of this disease include:
At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in individuals in the sixty-five to seventy-five range. However, numerous malignancies, including pancreatic cancer, have become more common in younger adults.
“Pancreatic cancer diagnosed prior to fifty is deemed uncommon, yet concerningly, clinicians are beginning to see a rising count of younger patients suffering from this condition,” said a specialist.
Without reliable detection methods for this malignancy, experts emphasized the importance of understanding your relatives’ health background. Some contributing elements, such as smoking and excess weight also play a role in the onset of pancreatic cancer.
Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.
“The initial action toward lowering one’s risk of this condition is assessing individual susceptibility. Individuals should examine their genetic background, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may increase their vulnerability,” advised a specialist.
Inherited genetic risk factors are linked to as much as ten percent of all pancreatic cancer cases. If someone in your household has had pancreatic cancer, you may want to think about DNA analysis.
“For people with a relative’s background of pancreatic cancer or those carrying high risk genetic mutations, checking may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he explained.
For those wishing to lower their chance, habit adjustments may make a difference. The most effective step you can take to lower your risk of this disease is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.
Heavy drinking is linked to pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding drinks may assist lower your chance.
Managing your body mass or losing weight may also aid reduce your risk. People with obesity are 20% more likely to get this disease. This malignancy also is more frequent in those with blood sugar issues, and weight loss can also lower the chance of adult-onset diabetes.
In spite of pancreatic cancer’s poor prognosis, there is still hope.
“We are making progress with therapies and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” said a specialist.
For numerous people, however, education about this rare but {dev
Maya Chen is an HR consultant with over 10 years of experience in performance management and organizational development.